UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Scoping review of measures of treatment burden in patients with multimorbidity: advancements and current gaps

Mendoza-Quispe, D; Perez-Leon, S; Alarcon-Ruiz, CA; Gaspar, A; Cuba-Fuentes, MS; Zunt, JR; Montori, VM; ... Miranda, JJ; + view all (2023) Scoping review of measures of treatment burden in patients with multimorbidity: advancements and current gaps. Journal of Clinical Epidemiology , 159 pp. 92-105. 10.1016/j.jclinepi.2023.05.013. Green open access

[thumbnail of 1-s2.0-S0895435623001269-main.pdf]
Preview
Text
1-s2.0-S0895435623001269-main.pdf - Published Version

Download (663kB) | Preview

Abstract

Objectives: To identify, assess, and summarize the measures to assess burden of treatment in patients with multimorbidity (BoT-MMs) and their measurement properties. Study Design and Setting: MEDLINE via PubMed was searched from inception until May 2021. Independent reviewers extracted data from studies in which BoT-MMs were developed, validated, or reported as used, including an assessment of their measurement properties (e.g., validity and reliability) using the COnsensus-based Standards for the selection of health Measurement INstruments. Results: Eight BoT-MMs were identified across 72 studies. Most studies were performed in English (68%), in high-income countries (90%), without noting urban-rural settings (90%). No BoT-MMs had both sufficient content validity and internal consistency; some measurement properties were either insufficient or uncertain (e.g., responsiveness). Other frequent limitations of BoT-MMs included absent recall time, presence of floor effects, and unclear rationale for categorizing and interpreting raw scores. Conclusion: The evidence needed for use of extant BoT-MMs in patients with multimorbidity remains insufficiently developed, including that of suitability for their development, measurement properties, interpretability of scores, and use in low-resource settings. This review summarizes this evidence and identifies issues needing attention for using BoT-MMs in research and clinical practice.

Type: Article
Title: Scoping review of measures of treatment burden in patients with multimorbidity: advancements and current gaps
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.jclinepi.2023.05.013
Publisher version: https://doi.org/10.1016/j.jclinepi.2023.05.013
Language: English
Additional information: © 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/ 4.0/).
Keywords: Chronic disease, Cost of illness, Multimorbidity, Patient-reported outcome measures, Scoping review, Surveys and questionnaires
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Primary Care and Population Health
URI: https://discovery.ucl.ac.uk/id/eprint/10172911
Downloads since deposit
21Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item